EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $330 | -90.7% | 17 | -86.4% | 0.00% | – |
| Q1 2023 | $3,546 | +137.8% | 125 | +145.1% | 0.00% | – |
| Q4 2022 | $1,491 | +49.1% | 51 | +6.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 48 | +45.5% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 33 | -36.5% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 52 | -40.2% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 87 | +102.3% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 43 | +65.4% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 26 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 26 | -44.7% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 47 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 47 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |